• Published 2017

Nitric Oxide Donors and Cardiovascular Agents Modulating the Bioactivity of Nitric Oxide : An Overiew ”

@inproceedings{Sharma2017NitricOD,
  title={Nitric Oxide Donors and Cardiovascular Agents Modulating the Bioactivity of Nitric Oxide : An Overiew ”},
  author={Meenakshi Sharma},
  year={2017}
}
EP O317956 5, 1989 WO WO97/.46521 12/1997 WO WO98/42661 10, 1998 WO WO99,58152 11, 1999 WO WOOO,54756 9, 2000 WO WOOO64483 11, 2000 WO WOO1? 13957 3, 2001 WO WOO1/49275 A2 T 2001 WO WOO3(OOO643 A1 1, 2003 WO WO 03/040 104 5, 2003 WO WO2004/004648 A2 1, 2004 WO WO2004/O12659 A2 2, 2004 WO WO 2004/O39771 5, 2004 WO WO 2004/0691.59 8, 2004 WO WO2004f1 10432 A1 12/2004 WO WO2005/030 135 A2 4/2005 Smith et al. “Urethans of 2-Mercaptoethanol” Journal of the Ameri can Chemical Society, 1959, vol. 81… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-7 OF 7 CITATIONS

Controlled Delivery of Nitric Oxide for Cancer Therapy

VIEW 1 EXCERPT
CITES BACKGROUND

The cytoprotective effects of Δ-17 fatty acid desaturase on injured HUVECs and its underlying mechanism

VIEW 1 EXCERPT
CITES BACKGROUND

References

Publications referenced by this paper.
SHOWING 1-4 OF 4 REFERENCES

1260-1262) or by treatment of sul fonyl chloride with silver cyanate

  • Org. Chem
  • 1965
VIEW 8 EXCERPTS
HIGHLY INFLUENTIAL

New York (1999), the disclosures of which are incorporated herein by reference. Suitable protecting groups (PGs) include, but not limited to, acetyl

  • edition, John Wiley, Sons, Inc
  • 1999

Molecules with two or more carboxylic acid groups may form mono

  • N. Y. York
  • di-, tri-,
  • 1991
VIEW 2 EXCERPTS

Science is an international health Science pub lishing company, established in 1958 and headquartered

  • pounds. Prous
  • 1958